Keyphrases
Randomized Controlled Trial
100%
Angiotensin
100%
Propofol
100%
Methohexital
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
37%
Anesthetic Induction
37%
Angiotensin Receptor Blockers
37%
Hypotension
25%
Hemodynamic Stability
25%
Induction Agents
25%
Between-group
12%
Hormone Levels
12%
Blood Samples
12%
Heart Rate
12%
Systolic Blood Pressure
12%
Diastolic Blood Pressure
12%
Pharmacologic
12%
Angiotensin II (Ang II)
12%
Epinephrine
12%
Hypertensive Patients
12%
Withholding
12%
Noncardiac Surgery
12%
Neurohormone
12%
Hemodynamic Parameters
12%
Arginine Vasopressin
12%
Hemodynamic Profile
12%
Equus
12%
Anesthetic Dose
12%
Refractory Hypotension
12%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Angiotensin
100%
Methohexital
100%
Propofol
100%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Hypotension
37%
Angiotensin Receptor Antagonist
37%
Epinephrine
12%
Angiotensin II
12%
Noradrenalin
12%
Equus
12%
Neurohormone
12%
Argipressin
12%
Neuroscience
Angiotensin
100%
Randomized Controlled Trial
100%
Methohexital
100%
Propofol
100%
ACE Inhibitor
37%
Angiotensin Receptor
37%
Epinephrine
12%
Angiotensin II
12%
Norepinephrine
12%
Argipressin
12%
Neurohormone
12%
Nursing and Health Professions
Propofol
100%
Angiotensin
100%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Hypotension
37%
Anesthesia Induction
25%
Diastolic Blood Pressure
12%
Systolic Blood Pressure
12%
Angiotensin II
12%
Hormone Determination
12%
Adrenalin Blood Level
12%
Noradrenalin Blood Level
12%
Neurohormone
12%
Argipressin
12%